Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman R M
Department of Zoology, Faculty of Science, Kyoto University, Japan.
J Exp Med. 1992 Dec 1;176(6):1693-702. doi: 10.1084/jem.176.6.1693.
Antigen-presenting, major histocompatibility complex (MHC) class II-rich dendritic cells are known to arise from bone marrow. However, marrow lacks mature dendritic cells, and substantial numbers of proliferating less-mature cells have yet to be identified. The methodology for inducing dendritic cell growth that was recently described for mouse blood now has been modified to MHC class II-negative precursors in marrow. A key step is to remove the majority of nonadherent, newly formed granulocytes by gentle washes during the first 2-4 d of culture. This leaves behind proliferating clusters that are loosely attached to a more firmly adherent "stroma." At days 4-6 the clusters can be dislodged, isolated by 1-g sedimentation, and upon reculture, large numbers of dendritic cells are released. The latter are readily identified on the basis of their distinct cell shape, ultrastructure, and repertoire of antigens, as detected with a panel of monoclonal antibodies. The dendritic cells express high levels of MHC class II products and act as powerful accessory cells for initiating the mixed leukocyte reaction. Neither the clusters nor mature dendritic cells are generated if macrophage colony-stimulating factor rather than granulocyte/macrophage colony-stimulating factor (GM-CSF) is applied. Therefore, GM-CSF generates all three lineages of myeloid cells (granulocytes, macrophages, and dendritic cells). Since > 5 x 10(6) dendritic cells develop in 1 wk from precursors within the large hind limb bones of a single animal, marrow progenitors can act as a major source of dendritic cells. This feature should prove useful for future molecular and clinical studies of this otherwise trace cell type.
已知提呈抗原的、富含主要组织相容性复合体(MHC)II类分子的树突状细胞起源于骨髓。然而,骨髓中缺乏成熟的树突状细胞,大量增殖的未成熟细胞尚未被鉴定出来。最近描述的用于诱导小鼠血液中树突状细胞生长的方法现已应用于骨髓中MHC II类阴性前体细胞。关键步骤是在培养的最初2 - 4天通过轻柔冲洗去除大部分非贴壁的新形成的粒细胞。这样就留下了松散附着于更牢固贴壁的“基质”上的增殖细胞簇。在第4 - 6天,这些细胞簇可以被分离下来,通过1g沉降进行分离,再培养时,会释放出大量的树突状细胞。根据其独特的细胞形态、超微结构以及用一组单克隆抗体检测到的抗原谱,很容易识别出后者。这些树突状细胞表达高水平的MHC II类产物,并作为启动混合淋巴细胞反应的强大辅助细胞。如果应用巨噬细胞集落刺激因子而非粒细胞/巨噬细胞集落刺激因子(GM - CSF),则既不会产生细胞簇也不会产生成熟的树突状细胞。因此,GM - CSF可生成髓系细胞的所有三个谱系(粒细胞、巨噬细胞和树突状细胞)。由于在1周内从单只动物的大后肢骨内的前体细胞中可产生超过5×10⁶个树突状细胞,骨髓祖细胞可作为树突状细胞的主要来源。这一特性对于这种原本难以追踪的细胞类型的未来分子和临床研究应该是有用的。